Evidence map›Paper›PMID 41304910›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Anticancer and Immunomodulatory Effects of a Thiazolyl Benzodiazepine Targeting HSP90 in ER

Kubra Acikalin Coskun, Lutfi Tutar, Kezban Uçar Çifci, Mervenur Al, Irfan Koca, Mehmet Gumus, Levent Gulum, Emir Capkinoglu, Yusuf Tutar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Transcriptional Reprogramming of Cancer Metabolism:International journal of molecular sciences · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kubra Acikalin CoskunDivision of Medicinal Biology, Department of Basic Medical Sciences, Istanbul Aydın University, Istanbul 34295, Turkey.ORCID 0000-0002-0047-8368
Lutfi TutarDepartment of Molecular Biology and Genetics, Faculty of Science, Ahievran University, Kirsehir 40100, Turkey.
Kezban Uçar ÇifciHemp Research Institute, Yozgat Bozok University, Yozgat 66900, Turkey.
Mervenur AlDivision of Medicinal Biochemistry, Department of Basic Medical Sciences, University of Health Sciences, Istanbul 34668, Turkey.ORCID 0000-0002-2495-8358
Irfan KocaDivision of Organic Chemistry, Department of Chemistry, Faculty of Science, Yozgat Bozok University, Yozgat 66900, Turkey.ORCID 0000-0001-7873-159X
Mehmet GumusProgram of Civil Defense and Firefighting, Yozgat Vocational School, Yozgat 66900, Turkey.
Levent GulumMudurnu Sureyya Astarcı Vocational School, Abant Izzet Baysal University, Bolu 14030, Turkey.
Emir CapkinogluDepartment of General Surgery, Institute of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul 34638, Turkey.ORCID 0000-0002-4981-7623
Yusuf TutarDivision of Medicinal Biochemistry, Department of Basic Medical Sciences, Faculty of Medicine, Recep Tayyip Erdogan University, Rize 53100, Turkey.ORCID 0000-0003-2613-9644

Funding

Acibadem Mehmet Ali Aydinlar University EC1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer signalingERK/MAPKHSP90 inhibitionpathway crosstalkthiazolyl benzodiazepine

Identifiers

PMID41304910
PMCPMC12655246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.